Peer-Reviewed Publication

Science: Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern

View

Webinar

The new LSA-XT and high-throughput SPR characterization of multi-specific antibodies

View

Webinar

High resolution epitope binning informs antibody drug discovery and enhances next generation antibody workflows

View

Webinar

Exploring Carterra HT-SPR data using PerkinElmer Informatics Signals VitroVivo

View

Application Note

Increasing FcγR Characterization Throughput for Drug Candidates Using LSAXT

View

Application Note

Large-scale characterization of drug candidates against transmembrane receptors using HT-SPR

View

Application Note

Quantitation of IgG and His-tagged proteins using the Carterra LSA

View

Application Note

Carterra LSAXT characterization of kinase inhibitor selectivity and kinetics

View

Application Note

Increasing DNA Encoded Library (DEL) Screening Resolution Using HT-SPR

View

Peer-Reviewed Publication

Science: LY-CoV555, a Rapidly Isolated Potent Neutralizing Antibody, Provides Protection in a Non-Human Primate Model of SARS-CoV-2 Infection

View

Poster

Increasing DNA Encoded Library Screening Resolution Using HT-SPR

View

Application Note

High resolution FcRn IC50 potency measurements using the Carterra® LSA® platform

View

Application Note

Profiling antibody polyreactivity and polyspecificity using HT-SPR on the Carterra® LSA®

View

Webinar

The Transcendence of HT-SPR Technology Across Discovery Platforms and its Impact on Time-to-Clinic

View